Results 271 to 280 of about 213,320 (307)

Issues in Mandatory Economic Assessment of Pharmaceuticals

Health Affairs, 1992
Australia is expanding assessment of pharmaceuticals by requiring economic evaluation before drugs are marketed. While such assessment is voluntary at first for pharmaceutical firms, it becomes mandatory by January 1993. Michael Drummond has provided an excellent analysis of this new policy initiative, describing in detail the means, methods, and ...
openaire   +2 more sources

Economic impact of poor compliance with pharmaceuticals

Expert Review of Pharmacoeconomics & Outcomes Research, 2002
Poor compliance with prescribed drug regimens is a widespread phenomenon which results in decreased efficacy and is often associated with increased medical expenditures due to treatment failure and/or adverse events. This review examines the issues relating to the measurement of compliance and the clinical and economic consequences of noncompliant drug
openaire   +2 more sources

Economic evaluation of pharmaceuticals

2019
Around the world, health policy decision makers and payers are compelled to ensure delivery of quality health care under ever-tighter budgetary constraints and increasing demand. This is due to many factors, including ageing populations, expensive health technologies, and financial uncertainty.
Ademi, Zanfina, Liew, Danny
openaire   +1 more source

Economic evaluation of pharmaceuticals

1995
Bibliography: p. 23-27.
O'Brien, Bernie J., Centre for Health Economics and Policy Analysis   +1 more
openaire   +1 more source

Pharmaceutical economics

Health Policy, 1985
openaire   +2 more sources

Pharmaceutical Economics

Pharmaceutical Economics begins with an investigation of the structure of the industry and its three main components: the research firms which produce innovative products; the generic drug industry and its expanding role; and the biotech industry, which is regarded as the future for pharmaceuticals.
openaire   +1 more source

Price and Quality in the Generic Pharmaceutical Market

Circulation, 2022
Kevin A Schulman, Ben Teasdale MPhil
exaly  

Issues in Pharmaceutical Economics

Southern Economic Journal, 1980
Henry B. Steele, Robert Chien
openaire   +1 more source

Pharmaceutical Economics

Journal of the American Pharmaceutical Association (1961), 1961
openaire   +1 more source

Emerging trends: the involvement of community pharmacists in the planning and execution of pharmaceutical policies and economics

Expert Review of Pharmacoeconomics and Outcomes Research, 2023
Ali Alshahrani
exaly